Literature DB >> 16376055

Organization of heat shock dnaK and groE operons of the nosocomial pathogen Enterococcus faecium.

Marinella S Laport1, Leonardo Lima Dos Santos, José A C Lemos, Maria do Carmo F Bastos, Robert A Burne, Marcia Giambiagi-Demarval.   

Abstract

Enterococcus faecium is a frequently antibiotic-resistant opportunistic pathogen that is commonly recovered from hospitalized patients. The genetic organization of the dnaK operon was analyzed and was shown to consist of at least four heat shock genes, hrcA-grpE-dnaK-dnaJ. The dnaK/J intergenic region was 140 bp shorter than in E. faecalis. The dnaK operon was expressed from a putative sigma(A)-type promoter (PhrcA) upstream of the hrcA start codon and was preceded by two conserved CIRCE sequences. Northern hybridization revealed the presence of multiple mRNAs in the dnaK operon. Conversely, the groE operon was transcribed as a single mRNA. Induction of dnaK and groEL genes occurred in response to either heat shock or exposure to other stress agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376055     DOI: 10.1016/j.resmic.2005.06.010

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  2 in total

1.  clpB, a class III heat-shock gene regulated by CtsR, is involved in thermotolerance and virulence of Enterococcus faecalis.

Authors:  Naira Elane Moreira de Oliveira; Jaqueline Abranches; Anthony O Gaca; Marinella Silva Laport; Clarissa R Damaso; Maria do Carmo de Freire Bastos; José A Lemos; Marcia Giambiagi-deMarval
Journal:  Microbiology (Reading)       Date:  2010-12-09       Impact factor: 2.777

2.  Antimicrobial Activity of, and Cellular Pathways Targeted by, p-Anisaldehyde and Epigallocatechin Gallate in the Opportunistic Human Pathogen Pseudomonas aeruginosa.

Authors:  Yetunde Adewunmi; Sanchirmaa Namjilsuren; William D Walker; Dahlia N Amato; Douglas V Amato; Olga V Mavrodi; Derek L Patton; Dmitri V Mavrodi
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.